Disclosures for "CD11c+ B cells Are Fundamentally Altered in Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis")
-
Dr. Sikorski has nothing to disclose.
-
The institution of Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Kaminski has stock in ARC Biotechnology. The institution of Dr. Kaminski has received research support from National Institutes of Health. Dr. Kaminski has received publishing royalties from a publication relating to health care.
-
An immediate family member of Linda Kusner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. An immediate family member of Linda Kusner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. An immediate family member of Linda Kusner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Caballeta Bio. An immediate family member of Linda Kusner has stock in ARC Biotech. The institution of Linda Kusner has received research support from National Institutes of Health. The institution of an immediate family member of Linda Kusner has received research support from National Institutes of Health.